Redirecting to original paper in 30 seconds...

Click below to go immediately or wait for automatic redirect

arxiv_ml 95% Match Research Paper Computational chemists,Drug discovery scientists,Machine learning researchers,Optimization experts 19 hours ago

Gradient GA: Gradient Genetic Algorithm for Drug Molecular Design

graph-neural-networks › molecular-modeling
📄 Abstract

Abstract: Molecular discovery has brought great benefits to the chemical industry. Various molecule design techniques are developed to identify molecules with desirable properties. Traditional optimization methods, such as genetic algorithms, continue to achieve state-of-the-art results across multiple molecular design benchmarks. However, these techniques rely solely on random walk exploration, which hinders both the quality of the final solution and the convergence speed. To address this limitation, we propose a novel approach called Gradient Genetic Algorithm (Gradient GA), which incorporates gradient information from the objective function into genetic algorithms. Instead of random exploration, each proposed sample iteratively progresses toward an optimal solution by following the gradient direction. We achieve this by designing a differentiable objective function parameterized by a neural network and utilizing the Discrete Langevin Proposal to enable gradient guidance in discrete molecular spaces. Experimental results demonstrate that our method significantly improves both convergence speed and solution quality, outperforming cutting-edge techniques. For example, it achieves up to a 25% improvement in the top-10 score over the vanilla genetic algorithm. The code is publicly available at https://github.com/debadyuti23/GradientGA.

Key Contributions

The paper proposes Gradient GA, a novel approach that enhances traditional genetic algorithms for molecular design by incorporating gradient information from the objective function. This allows for guided exploration towards optimal solutions, improving both the quality of the final molecule and the speed of convergence compared to purely random exploration methods.

Business Value

Accelerates the discovery of new drugs and materials with desired properties, potentially reducing R&D costs and time-to-market for pharmaceutical and chemical companies.